Outset Medical
73 hedge funds and large institutions have $23.4M invested in Outset Medical in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 16 closing their positions.
118% more call options, than puts
Call options by funds: $159K | Put options by funds: $73K
6% less funds holding
Funds holding: 78 → 73 (-5)
9.95% less ownership
Funds ownership: 50.02% → 40.07% (-10%)
33% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 24
56% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 16
68% less capital inflows, than outflows
Capital inflows: $1.64M | Capital outflows: $5.11M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$526K |
| 2 |
Birchview Capital
Burlington,
Vermont
|
+$299K |
| 3 |
Morgan Stanley
New York
|
+$210K |
| 4 |
Squarepoint
New York
|
+$130K |
| 5 |
Two Sigma Investments
New York
|
+$108K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.23M |
| 2 |
Mubadala Investment Company
Abu Dhabi,
United Arab Emirates
|
-$975K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$917K |
| 4 |
Millennium Management
New York
|
-$412K |
| 5 |
D.E. Shaw & Co
New York
|
-$290K |
OM Hedge Fund Activity: Q4 2024 in Review
73 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q4 2024, worth a combined $23.4M — up 33% from $17.6M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of OM and 7 opened new positions — a net loss of 9 holders — while 24 trimmed existing stakes and 16 added.
The largest buyer was Renaissance Technologies, adding an estimated $526K. The largest seller was Ameriprise, exiting entirely with an estimated $1.23M sold.
- 73 institutional investors held Outset Medical (OM) as of Q4 2024, down from 78 in Q3 2024.
- Funds reported $23.4M of Outset Medical stock for Q4 2024, up 33% quarter-over-quarter.
- 7 funds opened new Outset Medical positions in Q4 2024 and 16 closed out, a net change of -9 holders.
- The largest Outset Medical buyer in Q4 2024 was Renaissance Technologies, an estimated $526K added.
- The largest Outset Medical seller in Q4 2024 was Ameriprise, an estimated $1.23M sold.
Based on aggregated 13F filings for Q4 2024.